Mark J. Niciu

5.9k total citations · 1 hit paper
66 papers, 4.3k citations indexed

About

Mark J. Niciu is a scholar working on Pharmacology, Biological Psychiatry and Cognitive Neuroscience. According to data from OpenAlex, Mark J. Niciu has authored 66 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pharmacology, 35 papers in Biological Psychiatry and 20 papers in Cognitive Neuroscience. Recurrent topics in Mark J. Niciu's work include Treatment of Major Depression (41 papers), Tryptophan and brain disorders (35 papers) and Functional Brain Connectivity Studies (18 papers). Mark J. Niciu is often cited by papers focused on Treatment of Major Depression (41 papers), Tryptophan and brain disorders (35 papers) and Functional Brain Connectivity Studies (18 papers). Mark J. Niciu collaborates with scholars based in United States, United Kingdom and Czechia. Mark J. Niciu's co-authors include Carlos A. Zarate, Erica M. Richards, David A. Luckenbaugh, Dawn F. Ionescu, Elizabeth D. Ballard, Allison C. Nugent, Nancy E. Brutsché, Rodrigo Machado‐Vieira, Gerard Sanacora and Benjamin Kelmendi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Biological Psychiatry.

In The Last Decade

Mark J. Niciu

64 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine

2016 334 citations Marc S. Lener, Mark J. Niciu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark J. Niciu United States	38	2.2k	1.9k	1.1k	880	736	66	4.3k
Nancy Diazgranados United States	25	2.6k 1.2×	2.2k 1.2×	1.3k 1.2×	745 0.8×	574 0.8×	79	4.5k
Paul J. Carlson United States	17	2.2k 1.0×	1.9k 1.0×	1.4k 1.2×	717 0.8×	375 0.5×	24	3.7k
Ioline D. Henter United States	40	1.9k 0.9×	2.0k 1.1×	1.2k 1.1×	531 0.6×	445 0.6×	81	4.8k
Giacomo Salvadore United States	25	1.7k 0.8×	1.6k 0.8×	906 0.8×	744 0.8×	408 0.6×	51	3.4k
Chadi G. Abdallah United States	39	2.2k 1.0×	1.9k 1.0×	1.4k 1.2×	1.8k 2.0×	635 0.9×	112	5.5k
Dan A. Oren United States	30	2.5k 1.1×	2.1k 1.1×	1.9k 1.6×	754 0.9×	595 0.8×	73	5.5k
Richard C. Shelton United States	31	1.5k 0.7×	1.1k 0.6×	818 0.7×	411 0.5×	561 0.8×	65	3.9k
Cristina Cusin United States	35	1.5k 0.7×	1.1k 0.6×	1.0k 0.9×	590 0.7×	597 0.8×	102	3.8k
Dawn F. Ionescu United States	32	2.1k 1.0×	1.6k 0.8×	658 0.6×	567 0.6×	821 1.1×	54	3.3k
Raffaella Zanardi Italy	38	1.5k 0.7×	909 0.5×	1.3k 1.2×	639 0.7×	610 0.8×	134	4.3k

Countries citing papers authored by Mark J. Niciu

Since Specialization

Citations

This map shows the geographic impact of Mark J. Niciu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Niciu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Niciu more than expected).

Fields of papers citing papers by Mark J. Niciu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Niciu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Niciu. The network helps show where Mark J. Niciu may publish in the future.

Co-authorship network of co-authors of Mark J. Niciu

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Niciu. A scholar is included among the top collaborators of Mark J. Niciu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Niciu. Mark J. Niciu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pace, Benjamin, et al.. (2023). Age effects on motor threshold. Brain stimulation. 16(4). 13–13.

Kadriu, Bashkim, Shiwen Yuan, Cristan Farmer, et al.. (2018). Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability. Journal of Clinical Psychopharmacology. 38(3). 243–246. 3 indexed citations

Ballard, Elizabeth D., Julia S. Yarrington, Cristan Farmer, et al.. (2018). Characterizing the course of suicidal ideation response to ketamine. Journal of Affective Disorders. 241. 86–93. 44 indexed citations

Ballard, Elizabeth D., Níall Lally, Erica M. Richards, et al.. (2017). Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials. Journal of Affective Disorders. 218. 195–200. 101 indexed citations

Niciu, Mark J., Dipavo Banerjee, David A. Luckenbaugh, et al.. (2017). The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder. Journal of Psychopharmacology. 31(12). 1570–1577. 18 indexed citations

Jutkiewicz, Emily M., Simon J. Evans, Chadi A. Calarge, et al.. (2016). ACNP 55th Annual Meeting: Panels, Mini-Panels and Study Groups. Neuropsychopharmacology. 41(S1). S1–S115.

Machado‐Vieira, Rodrigo, Philip W. Gold, David A. Luckenbaugh, et al.. (2016). The role of adipokines in the rapid antidepressant effects of ketamine. Molecular Psychiatry. 22(1). 127–133. 82 indexed citations

Richards, Erica M., Daniel C. Mathews, David A. Luckenbaugh, et al.. (2016). A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression. Psychopharmacology. 233(6). 1119–1130. 59 indexed citations

Niciu, Mark J., Níall Lally, Erica M. Richards, et al.. (2016). Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder. Current Neuropharmacology. 15(1). 57–70. 76 indexed citations

10.

Niciu, Mark J., et al.. (2016). Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion. Journal of Affective Disorders. 208. 560–566. 56 indexed citations

11.

Ballard, Elizabeth D., Rebecca A. Bernert, David A. Luckenbaugh, et al.. (2016). Nocturnal Wakefulness Is Associated With Next-Day Suicidal Ideation in Major Depressive Disorder and Bipolar Disorder. The Journal of Clinical Psychiatry. 77(6). 825–831. 54 indexed citations

12.

Lally, Níall, Allison C. Nugent, David A. Luckenbaugh, et al.. (2015). Neural correlates of change in major depressive disorder anhedonia following open-label ketamine. Journal of Psychopharmacology. 29(5). 596–607. 165 indexed citations

13.

Ballard, Elizabeth D., David A. Luckenbaugh, Erica M. Richards, et al.. (2015). Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant. Journal of Psychiatric Research. 68. 68–73. 56 indexed citations

14.

Niciu, Mark J., David A. Luckenbaugh, Dawn F. Ionescu, et al.. (2014). Ketamine’s Antidepressant Efficacy is Extended for at Least Four Weeks in Subjects with a Family History of an Alcohol Use Disorder. The International Journal of Neuropsychopharmacology. 18(1). 45 indexed citations

15.

Luckenbaugh, David A., Mark J. Niciu, Dawn F. Ionescu, et al.. (2014). Do the dissociative side effects of ketamine mediate its antidepressant effects?. Journal of Affective Disorders. 159. 56–61. 220 indexed citations

16.

Niciu, Mark J., Dawn F. Ionescu, Daniel C. Mathews, Erica M. Richards, & Carlos A. Zarate. (2013). Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part I: major depressive disorder. CNS Spectrums. 18(5). 231–241. 37 indexed citations

17.

Niciu, Mark J., Ioline D. Henter, Gerard Sanacora, & Carlos A. Zarate. (2013). Glial abnormalities in substance use disorders and depression: Does shared glutamatergic dysfunction contribute to comorbidity?. The World Journal of Biological Psychiatry. 15(1). 2–16. 27 indexed citations

18.

Niciu, Mark J., Dawn F. Ionescu, Erica M. Richards, & Carlos A. Zarate. (2013). Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder. Journal of Neural Transmission. 121(8). 907–924. 123 indexed citations

19.

Niciu, Mark J., Xin‐Ming Ma, Rajaâ El Meskini, et al.. (2007). Altered ATP7A expression and other compensatory responses in a murine model of Menkes disease. Neurobiology of Disease. 27(3). 278–291. 53 indexed citations

20.

Niciu, Mark J., Xin‐Ming Ma, Rajaâ El Meskini, et al.. (2006). Developmental changes in the expression of ATP7A during a critical period in postnatal neurodevelopment. Neuroscience. 139(3). 947–964. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact